Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - An Anglo-French collaborative report

European Journal of Cancer

Volumn 48, Issue 11, 2012, Pages 1700-1706

  Shankar, Ananth ^a   Hall, Georgina W ^b   Gorde Grosjean, Stephanie ^c   Hasenclever, Dirk ^d   Leblanc, Thierry ^e   Hayward, Janis ^f   Lambilliotte, Anne ^g   Daw, Stephen ^a   Perel, Yves ^h   McCarthy, Keith ⁱ   Lejars, Odile ^j   Coulomb, Aurore ^k   Oberlin, W Odile ^l   Wallace, W Hamish ^m   Landman Parker, Judith ^k  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c REIMS UNIVERSITY HOSPITAL   (France)

^d Institut für Medizinische Informatik   (Germany)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g LILLE UNIVERSITY HOSPITAL   (France)

^h BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁱ CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^j UNIVERSITY HOSPITAL OF TOURS   (France)

^k ARMAND TROUSSEAU HOSPITAL   (France)

^l INSTITUT GUSTAVE ROUSSY   (France)

^m ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

more..

Author keywords

CVP; Early stage; Nodular lymphocyte predominant hodgkin lymphoma; Overall survival; Relapse

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE; VINBLASTINE;

ADOLESCENT; ANEMIA; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; SCHOOL CHILD; THROMBOCYTOPENIA;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FEMALE; HODGKIN DISEASE; HUMANS; MALE; PREDNISOLONE; TREATMENT OUTCOME; VINBLASTINE;

EID: 84862768406     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.10.018     Document Type: Article

References (30)

1. C. Sandoval, L. Venkateswaran, and C. Billups Lymphocyte-predominant Hodgkin disease in children J Pediatr Hematol Oncol 24 2002 269 273
2. B. Pellegrino, M.J. Terrier-Lacombe, and O. Oberlin Lymphocyte- predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection - a Study of the French Society of Pediatric Oncology J Clin Oncol 21 2003 2948 2952
3. S.B. Murphy, E.R. Morgan, H.M. Katzenstein, and M. Kletzel Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents J Pediatr Hematol Oncol 25 2003 684 687
4. Shankar A, Daw S, Gorde-Grosjean S, et al. Treatment of children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma with a low intensity short duration chemotherapy regimen [CVP] - on behalf of the EuroNet-PHL. Group ASH abstract # 2471; 2006.
5. J.A. Alvarez, R.E. Scully, and T.L. Miller Long-term effects of treatments for childhood cancers Curr Opin Pediatr 19 2007 23 31
6. L.S. Constine, N. Tarbell, and M.M. Hudson Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose Int J Radiat Oncol Biol Phys 72 2008 24 33
7. R.C. Chen, M.S. Chin, and A.K. Ng Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up J Clin Oncol 28 2010 136 141
8. M.M. O'Brien, S.S. Donaldson, R.R. Balise, A.S. Whittemore, and M.P. Link Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy J Clin Oncol 28 2010 1232 1239
9. D.P. Regula Jr. , R.T. Hoppe, and L.M. Weiss Nodular and diffuse types of lymphocyte predominance Hodgkin's disease N Engl J Med 318 1988 214 219
10. V.I. Pappa, A.J. Norton, and R.K. Gupta Nodular type of lymphocyte predominant Hodgkin's disease: a clinical study of 50 cases Ann Oncol 6 1995 559 565
11. S. Bodis, M.D. Kraus, and G. Pinkus Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease J Clin Oncol 15 1997 3060 3066
12. G. Karayalcin, F.G. Behm, and P.W. Gieser Lymphocyte predominant Hodgkin disease: clinico-pathologic features and results of treatment - the Pediatric Oncology Group experience Med Pediatr Oncol 29 1997 519 525
13. V. Diehl, M. Sextro, and J. Franklin Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease J Clin Oncol 17 1999 776 783
14. G.W. Hall, N. Katzilakis, and C.R. Pinkerton Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report Br J Haematol 138 2007 761 768
15. P.P. Carbone, H.S. Kaplan, K. Musshoff, D.W. Smithers, and M. Tubiana Report of the Committee on Hodgkin's disease staging classification Cancer Res 31 1971 1860 1861
16. C. Mauz-Körholz, S. Gorde-Grosjean, and D. Hasenclever Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma Cancer 110 2007 179 185
17. K. London, S. Cross, E. Onikul, L. Dalla-Pozza, and R. Howman-Giles 18F-FDG PET/CT in paediatric lymphoma: comparison with conventional imaging Eur J Nucl Med Mol Imaging 38 2011 274 284
18. C. Furth, I.G. Steffen, and H. Amthauer Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial J Clin Oncol 27 2009 4385 4391
19. C. Ansquer, T. Hervouët, and A. Devillers 18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's disease Haematologica 93 2008 128 131
20. R.J. Mody, C. Bui, R.J. Hutchinson, K.A. Frey, and B.L. Shulkin Comparison of (18)F flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma Leuk Lymphoma 48 2007 699 707
21. H.T. Eich, S. Staar, and A. Gossmann German Hodgkin Lymphoma Study Group. The HD12 panel of the German Hodgkin Lymphoma Study Group (GHSG): a quality assurance program based on a multidisciplinary panel reviewing all patients' imaging Am J Clin Oncol 27 2004 279 284
22. H.T. Eich, S. Staar, and A. Gossmann German Hodgkin Study Group. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group Int J Radiat Oncol Biol Phys 58 2004 1121 1127
23. M. van Grotel, K.H. Lam, and R. de Man High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only Leuk Lymphoma 47 2006 1504 1510
24. M. Miettinen, K.O. Franssila, and E. Saxén Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas Cancer 51 1983 2293 2300
25. W.C. Chan Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: immunophenotypic and molecular studies Semin Hematol 36 1999 242 252
26. J.Z. Huang, D.D. Weisenburger, and J.M. Vose Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group Leuk Lymphoma 45 2004 1551 1557
27. I. Biasoli, A. Stamatoullas, and V. Meignin Nodular, lymphocyte- predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group Cancer 116 2010 631 639
28. D.M. Grossman, C.A. Hanson, and B. Schnitzer Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma Am J Surg Pathol 15 1991 668 676
29. W.H. Wallace, R.A. Anderson, and D.S. Irvine Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 6 2005 209 218
30. S.S. Donaldson, M.P. Link, and H.J. Weinstein Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease J Clin Oncol 25 2007 332 337